Adult intensive care unit use at the end of life: A population-based study

Mayo Clinic Proceedings

Volumn 81, Issue 7, 2006, Pages 896-901

  Seferian, Edward G ^a   Afessa, Bekele ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH CARE DELIVERY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POPULATION RESEARCH; RETROSPECTIVE STUDY; SURVIVAL; TERMINAL CARE;

EID: 33745621063     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.7.896     Document Type: Article

References (24)

1. Angus DC, Bamato AE, Linde-Zwirble WT, et al, Robert Wood Johnson Foundation ICU End-of-Life Peer Group. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med. 2004;32:638-643.
2. Wennberg JE, Cooper MM. The Quality of Medical Care in the United States: A Report on the Medicare Program. Chicago, Ill: American Hospital Publishing; 1999. The Dartmouth Atlas of Health Care in the United States Series.
3. Lynn J, Harrell F Jr, Cohn F, Wagner D, Connors AF Jr. Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy. New Horiz. 1997;5:56-61.
4. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J Jr, Committee on Manpower for Pulmonary and Critical Care Societies (COMPACCS). Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA. 2000;284:2762-2770.
5. Rice DP, Fineman N. Economic implications of increased longevity in the United States. Annu Rev Public Health. 2004;25:457-473.
6. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
7. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med. 1983;11:1-3.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
9. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45: 613-619.
10. Nobrega FT, Krishan I, Smoldt RK, et al. Hospital use in a fee-for-service system. JAMA. 1982;247:806-810.
11. Seferian EG, Afessa B. Demographic and clinical variation of adult intensive care unit utilization from a geographically defined population. Crit Care Med. In press.
12. SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT) [published correction appears in JAMA. 1996;275:1232]. JAMA. 1995;274:1591-1598.
13. Pritchard RS, Fisher ES, Teno JM, et al, Support Investigators. Influence of patient preferences and local health system characteristics on the place of death J Am Geriatr Soc. 1998;46:1242-1250.
14. Koelling TM, Chen RS, Lubwama RN, L'Italien GJ, Eagle KA. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J. 2004;147:74-78.
15. Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998;158:1163-1167.
16. Hoover DR, Crystal S, Kumar R, Sambamoorthi U, Cantor JC. Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey. Health Serv Res. 2002;37:1625-1642.
17. Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med. 2000;342:1409-1415.
18. Wennberg JE, Fisher ES, Stukel TA, Sharp SM. Use of Medicare claims data to monitor provider-specific performance among patients with severe chronic illness. Health Aff (Millwood). 2004;Suppl Web Exclusive:VAR5-18.
19. Skinner J, Wennberg JE. How Much is Enough? Efficiency and Medicare Spending in the Last Six Months of Life. Cambridge, Mass: National Bureau of Economic Research; 1998. Working Paper 6513.
20. Chernew ME, Hirth RA, Cutler DM. Increased spending on health care: how much can the United States afford? Health Aff (Millwood). 2003;22:15-25.
21. Luce JM, Rubenfeld GD. Can health care costs be reduced by limiting intensive care at the end of life? Am J Respir Crit Care Med. 2002;165:750-754.
22. Bernard GR, Vincent J-L, Laterre P-F, et al, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
23. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
24. Afessa B, Keegan MT, Hubmayr RD, et al. Evaluating the performance of an institution using an intensive care unit benchmark. Mayo Clin Proc. 2005; 80:174-180.